Details for New Drug Application (NDA): 020267
✉ Email this page to a colleague
NDA 020267 describes JUNIOR STRENGTH ADVIL, which is a drug marketed by Haleon Us Holdings and is included in two NDAs. It is available from two suppliers. Additional details are available on the JUNIOR STRENGTH ADVIL profile page.
The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-three suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-three suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020267
| Tradename: | JUNIOR STRENGTH ADVIL |
| Applicant: | Haleon Us Holdings |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Pharmacology for NDA: 020267
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 020267
Suppliers and Packaging for NDA: 020267
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| JUNIOR STRENGTH ADVIL | ibuprofen | TABLET;ORAL | 020267 | NDA | Haleon US Holdings LLC | 0573-0175 | 0573-0175-11 | 1 BOTTLE in 1 CARTON (0573-0175-11) / 24 TABLET, COATED in 1 BOTTLE |
Profile for product number 002
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Dec 13, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
